Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 34 Schemes (12.87%)
Foreign Institutions
Held by 66 Foreign Institutions (8.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2026)
Net Profit:
-93 Million
Pharmaceuticals & Biotechnology
USD 3,155 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.01
-999,999.00%
10.47






